Home/Filings/4/0001415889-25-007398
4//SEC Filing

FITZPATRICK LINDA A 4

Accession 0001415889-25-007398

CIK 0001382101other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:12 PM ET

Size

10.0 KB

Accession

0001415889-25-007398

Insider Transaction Report

Form 4
Period: 2025-03-05
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Transactions
  • Exercise/Conversion

    Restricted Stock Unit (RSU)

    2025-03-058,7500 total
    Exp: 2025-03-05Common Stock (8,750 underlying)
  • Tax Payment

    Common Stock

    2025-03-05$1.36/sh3,594$4,88895,433 total
  • Exercise/Conversion

    Common Stock

    2025-03-05+8,75099,027 total
Holdings
  • Common Stock

    (indirect: By Trust)
    10,383
Footnotes (4)
  • [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
  • [F2]These securities are held of record by Michael A. Fitzpatrick and Linda A. Fitzpatrick, Trustees of the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.
  • [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
  • [F4]The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date.

Issuer

SUTRO BIOPHARMA, INC.

CIK 0001382101

Entity typeother

Related Parties

1
  • filerCIK 0001188953

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:12 PM ET
Size
10.0 KB